Diagnostic Testing of STDs; Help Get the Treatment People Need and Prevent the Spread of Disease

 

Diagnostic Testing of STDs
Diagnostic Testing of STDs

Diagnostic testing of STDs are used to identify and diagnose sexually transmitted diseases (STIs). STDs, also known as sexually transmitted infections (STIs), are very common. STDs are infections that are transmitted during vaginal, anal, and oral sex. They are very common and several people who have them don't show any symptoms. STDs pass from one person to another through vaginal, oral, and anal sex. Testing for a STD in people who doesn't have symptoms is called screening. Most of the time, the screening is not a routine part of health care.

The Global Diagnostic Testing of STDs Market is estimated to account for US$ 290,128.2 Mn in terms of value by the end of 2027.

Screening is recommended for everyone aged 13 years to 64 years, people born between 1945 and 1965, pregnant women, women age 21 years and older, women who are sexually active, men who have sex with men, people with HIV, and people who have a new partner. If diagnostic testing for an STD shows that people have an STI, their sexual partners, including current partners and any other partners during the past three months to one year, need to be informed so that they can get tested. If they're infected, they can then be treated.

According to the World Health Organization (WHO), more than one million sexually transmitted infections (STIs) are acquired every day worldwide. STDs/STIs that cannot be cured. People with an STI caused by a virus will be infected for life and will always be at risk of infecting their sexual partners. Antibiotics, a single dose, can cure sexually transmitted bacterial and parasitic infections. STDs cannot be cured, but symptoms can be managed with medications. Trichomoniasis (or Trich) is the most common curable sexually transmitted disease.

In May 2022, Abbott announced received the U.S. Food and Drug Administration (FDA) clearance for its Alinity m STI Assay. The test simultaneously detects and differentiates 4 common sexually transmitted infections (STIs). STIs, when left untreated, can lead to severe health complications, including increased risk of getting certain cancers and infertility.

Comments

Post a Comment

Popular posts from this blog

Recycled Construction Aggregates Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Image
  Recycled Construction Aggregates Market Introduction: The Recycled Construction Aggregates Market has gained significant traction in recent years, driven by increasing environmental concerns, resource scarcity, and the growing emphasis on sustainable construction practices. Recycled construction aggregates, derived from the processing and recycling of construction and demolition waste materials, offer several benefits such as reduced demand for virgin materials, decreased landfill waste, and lower carbon footprint. The market for recycled construction aggregates is expected to witness substantial growth and present lucrative opportunities for market players. Market Size and Share: The global recycled construction aggregates market is projected to surpass  6.2 million tons  by the end of 2027 in terms of volume, exhibiting a CAGR of  6.0%  during the forecast period  (2020 to 2027) . The market is driven by stringent environmental regulations, governmen...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more